Gurugram IVF Case: DNA Tests Allegedly Show No Biological Link Between Couple and Twins
A couple from Gurugram who underwent In Vitro Fertilisation (IVF) in 2025 gave birth to twin daughters in January 2026. Soon after, they noticed significant physical differences between themselves and the children. Concerned, they arranged independent DNA testing, which allegedly revealed that neither parent was biologically related to either child. An FIR has been registered against the hospital involved, and the case is under investigation.
This incident raises fundamental questions about trust, oversight, and accountability in India's assisted reproductive technology (ART) sector. The couple's distress is compounded by the uncertainty surrounding their children's biological origins, and the rights and welfare of the twins are at stake.
The case is not isolated. In 2023, the National Consumer Disputes Redressal Commission imposed a substantial penalty on a Delhi hospital after DNA testing established that a husband was not the biological father of twins born following an Intracytoplasmic Sperm Injection (ICSI) procedure, where his sperm was claimed to have been used. That case exposed lapses in traceability and accountability within ART clinics.
The Gurugram case, while still under investigation, highlights persistent weaknesses in the regulation of ARTs in India. Robust systems for verifying gamete usage, maintaining chain of custody, and ensuring transparency are urgently needed to protect patients and children born through these technologies. The government has recently introduced the Assisted Reproductive Technology (Regulation) Act, 2021, but implementation and enforcement remain challenges.
Experts emphasise that in addition to legal repercussions, clinics must adopt stringent protocols to prevent mix-ups and ensure that patients can trust the process. The emotional and psychological impact on families affected by such errors cannot be overstated.
